Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 3/2010

01-05-2010

Ependymomas in Adults

Authors: Mark R. Gilbert, Roberta Ruda, Riccardo Soffietti

Published in: Current Neurology and Neuroscience Reports | Issue 3/2010

Login to get access

Abstract

Ependymomas are rare primary central nervous system tumors in adults. They occur most commonly in the spinal cord, where histopathologic evaluation is critical to differentiate the grade I myxopapillary ependymoma from the grade II ependymoma or grade III anaplastic ependymoma. Brain ependymomas are either grade II or III. Treatment for all grades and types includes maximum surgical resection. For myxopapillary ependymoma, complete removal while maintaining capsule integrity may be curative. Some grade II ependymomas may be observed carefully after imaging confirms complete resection, but grade III tumors require adjuvant radiation treatment. Radiation commonly is given to the region of tumor, except in cases in which there is imaging or cerebrospinal fluid evidence of tumor dissemination. Chemotherapy has not been studied extensively, although most reports suggest only modest benefit. Ongoing laboratory studies have uncovered important signal transduction pathways that may be better therapeutic targets, leading to the development of clinical trials using targeted agents.
Literature
1.
go back to reference Louis DN, Ohgaki H, Wiestler OD, et al.: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 2007, 114(2):97–109.CrossRef Louis DN, Ohgaki H, Wiestler OD, et al.: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 2007, 114(2):97–109.CrossRef
2.
go back to reference Godfraind C: Classification and controversies in pathology of ependymomas. Childs Nerv Syst 2009, 25(10):1185–1193.CrossRefPubMed Godfraind C: Classification and controversies in pathology of ependymomas. Childs Nerv Syst 2009, 25(10):1185–1193.CrossRefPubMed
3.
go back to reference Mack SC, Taylor MD: The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 2009, 25(10):1195–1201.CrossRefPubMed Mack SC, Taylor MD: The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 2009, 25(10):1195–1201.CrossRefPubMed
4.
go back to reference Tihan T, Zhou T, Holmes E, et al.: The prognostic value of histological grading of posterior fossa ependymomas in children: a Children’s Oncology Group study and a review of prognostic factors. Mod Pathol 2008, 21(2):165–177.PubMed Tihan T, Zhou T, Holmes E, et al.: The prognostic value of histological grading of posterior fossa ependymomas in children: a Children’s Oncology Group study and a review of prognostic factors. Mod Pathol 2008, 21(2):165–177.PubMed
5.
go back to reference Guyotat J, Signorelli F, Desme S, et al.: Intracranial ependymomas in adult patients: analyses of prognostic factors. J Neurooncol 2002, 60(3):255–268.CrossRefPubMed Guyotat J, Signorelli F, Desme S, et al.: Intracranial ependymomas in adult patients: analyses of prognostic factors. J Neurooncol 2002, 60(3):255–268.CrossRefPubMed
6.
go back to reference Metellus P, Barrie M, Figarella-Branger D, et al.: Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain 2007, 130(Pt 5):1338–1349.CrossRefPubMed Metellus P, Barrie M, Figarella-Branger D, et al.: Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain 2007, 130(Pt 5):1338–1349.CrossRefPubMed
7.
go back to reference • Guyotat J, Metellus P, Giorgi R, et al.: Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien) 2009, 151(8):947–960. This is an important compilation of adult patients with infratentorial ependymoma.CrossRef • Guyotat J, Metellus P, Giorgi R, et al.: Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien) 2009, 151(8):947–960. This is an important compilation of adult patients with infratentorial ependymoma.CrossRef
8.
go back to reference • Rodriguez D, Cheung MC, Housri N, et al.: Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973–2005). J Surg Res 2009, 156(2):340–351. The authors provide a comprehensive review of ependymoma from the SEER database.CrossRefPubMed • Rodriguez D, Cheung MC, Housri N, et al.: Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973–2005). J Surg Res 2009, 156(2):340–351. The authors provide a comprehensive review of ependymoma from the SEER database.CrossRefPubMed
9.
go back to reference • Reni M, Brandes AA, Vavassori V, et al.: A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer 2004, 100(6):1221–1229. This is one of the larger series evaluating possible prognostic factors in adults with ependymoma.CrossRefPubMed • Reni M, Brandes AA, Vavassori V, et al.: A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer 2004, 100(6):1221–1229. This is one of the larger series evaluating possible prognostic factors in adults with ependymoma.CrossRefPubMed
10.
go back to reference • Armstrong TS, Vera-Bolanos E, Aldape K, et al.: Adult ependymal tumors: prognosis and the MDACC experience. Neuro Oncol 2010 (in press). This single-institution study of confirmed cases of ependymoma includes an analysis of presenting symptoms. • Armstrong TS, Vera-Bolanos E, Aldape K, et al.: Adult ependymal tumors: prognosis and the MDACC experience. Neuro Oncol 2010 (in press). This single-institution study of confirmed cases of ependymoma includes an analysis of presenting symptoms.
11.
go back to reference Chen CJ, Tseng YC, Hsu HL, Jung SM: Imaging predictors of intracranial ependymomas. J Comput Assist Tomogr 2004, 28(3):407–413.CrossRefPubMed Chen CJ, Tseng YC, Hsu HL, Jung SM: Imaging predictors of intracranial ependymomas. J Comput Assist Tomogr 2004, 28(3):407–413.CrossRefPubMed
12.
go back to reference Mendrzyk F, Korshunov A, Benner A, et al.: Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 2006, 12(7 Pt 1):2070–2079.CrossRefPubMed Mendrzyk F, Korshunov A, Benner A, et al.: Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 2006, 12(7 Pt 1):2070–2079.CrossRefPubMed
13.
go back to reference Tabori U, Wong V, Ma J, et al.: Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. Br J Cancer 2008, 99(7):1129–1135.CrossRefPubMed Tabori U, Wong V, Ma J, et al.: Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. Br J Cancer 2008, 99(7):1129–1135.CrossRefPubMed
14.
go back to reference Snuderl M, Chi SN, De Santis SM, et al.: Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol 2008, 67(9):911–920.CrossRefPubMed Snuderl M, Chi SN, De Santis SM, et al.: Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol 2008, 67(9):911–920.CrossRefPubMed
15.
go back to reference McGuire CS, Sainani KL, Fisher PG: Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 2009, 110(4):725–729.CrossRefPubMed McGuire CS, Sainani KL, Fisher PG: Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 2009, 110(4):725–729.CrossRefPubMed
16.
go back to reference Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States; 2005. Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States; 2005.
17.
go back to reference Scheil S, Bruderlein S, Eicker M, et al.: Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 2001, 11(2):133–143.PubMedCrossRef Scheil S, Bruderlein S, Eicker M, et al.: Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 2001, 11(2):133–143.PubMedCrossRef
18.
go back to reference Jeuken JW, Sprenger SH, Gilhuis J, et al.: Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol 2002, 197(2):238–244.CrossRefPubMed Jeuken JW, Sprenger SH, Gilhuis J, et al.: Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol 2002, 197(2):238–244.CrossRefPubMed
19.
go back to reference Modena P, Lualdi E, Facchinetti F, et al.: Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006, 24(33):5223–5233.CrossRefPubMed Modena P, Lualdi E, Facchinetti F, et al.: Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006, 24(33):5223–5233.CrossRefPubMed
20.
go back to reference Gilbertson RJ, Bentley L, Hernan R, et al.: ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 2002, 8(10):3054–3064.PubMed Gilbertson RJ, Bentley L, Hernan R, et al.: ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 2002, 8(10):3054–3064.PubMed
21.
go back to reference Lim M, Guccione S, Haddix T, et al.: alpha(v)beta(3) Integrin in central nervous system tumors. Hum Pathol 2005, 36(6):665–669.CrossRefPubMed Lim M, Guccione S, Haddix T, et al.: alpha(v)beta(3) Integrin in central nervous system tumors. Hum Pathol 2005, 36(6):665–669.CrossRefPubMed
22.
go back to reference de Bont JM, den Boer ML, Kros JM, et al.: Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis. J Neuropathol Exp Neurol 2007, 66(6):505–516.CrossRefPubMed de Bont JM, den Boer ML, Kros JM, et al.: Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis. J Neuropathol Exp Neurol 2007, 66(6):505–516.CrossRefPubMed
23.
go back to reference Roma AA, Prayson RA: Expression of cyclo-oxygenase-2 in ependymal tumors. Neuropathology 2006, 26(5):422–428.CrossRefPubMed Roma AA, Prayson RA: Expression of cyclo-oxygenase-2 in ependymal tumors. Neuropathology 2006, 26(5):422–428.CrossRefPubMed
24.
go back to reference De Bustos C, Smits A, Stromberg B, et al.: A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. J Med Genet 2005, 42(1):31–37.CrossRefPubMed De Bustos C, Smits A, Stromberg B, et al.: A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. J Med Genet 2005, 42(1):31–37.CrossRefPubMed
25.
go back to reference Lukashova-v Zangen I, Kneitz S, Monoranu CM, et al.: Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival. Acta Neuropathol 2007, 113(3):325–337.CrossRefPubMed Lukashova-v Zangen I, Kneitz S, Monoranu CM, et al.: Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival. Acta Neuropathol 2007, 113(3):325–337.CrossRefPubMed
26.
go back to reference Korshunov A, Neben K, Wrobel G, et al.: Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol 2003, 163(5):1721–1727.PubMed Korshunov A, Neben K, Wrobel G, et al.: Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol 2003, 163(5):1721–1727.PubMed
27.
go back to reference Suarez-Merino B, Hubank M, Revesz T, et al.: Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3. Neuro Oncol 2005, 7(1):20–31.CrossRefPubMed Suarez-Merino B, Hubank M, Revesz T, et al.: Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3. Neuro Oncol 2005, 7(1):20–31.CrossRefPubMed
28.
go back to reference Hamilton DW, Lusher ME, Lindsey JC, et al.: Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. Cancer Lett 2005, 227(1):75–81.CrossRefPubMed Hamilton DW, Lusher ME, Lindsey JC, et al.: Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. Cancer Lett 2005, 227(1):75–81.CrossRefPubMed
29.
go back to reference Michalowski MB, de Fraipont F, Michelland S, et al.: Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 2006, 166(1):74–81.CrossRefPubMed Michalowski MB, de Fraipont F, Michelland S, et al.: Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 2006, 166(1):74–81.CrossRefPubMed
30.
go back to reference Waha A, Koch A, Hartmann W, et al.: Analysis of HIC-1 methylation and transcription in human ependymomas. Int J Cancer 2004, 110(4):542–549.CrossRefPubMed Waha A, Koch A, Hartmann W, et al.: Analysis of HIC-1 methylation and transcription in human ependymomas. Int J Cancer 2004, 110(4):542–549.CrossRefPubMed
31.
go back to reference •• Taylor MD, Poppleton H, Fuller C, et al.: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8(4):323–335. These important laboratory studies strongly support the role of radial glial cells as the stem cells for ependymomas, providing the foundation for investigations of tumor biology and creation of laboratory models.CrossRefPubMed •• Taylor MD, Poppleton H, Fuller C, et al.: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8(4):323–335. These important laboratory studies strongly support the role of radial glial cells as the stem cells for ependymomas, providing the foundation for investigations of tumor biology and creation of laboratory models.CrossRefPubMed
32.
go back to reference Buccoliero AM, Castiglione F, Rossi Degl’Innocenti D, et al.: O6-Methylguanine-DNA-methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry. J Chemother 2008, 20(2):263–268.PubMed Buccoliero AM, Castiglione F, Rossi Degl’Innocenti D, et al.: O6-Methylguanine-DNA-methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry. J Chemother 2008, 20(2):263–268.PubMed
33.
go back to reference Kawabata Y, Takahashi JA, Arakawa Y, Hashimoto N: Long-term outcome in patients harboring intracranial ependymoma. J Neurosurg 2005, 103(1):31–37.CrossRefPubMed Kawabata Y, Takahashi JA, Arakawa Y, Hashimoto N: Long-term outcome in patients harboring intracranial ependymoma. J Neurosurg 2005, 103(1):31–37.CrossRefPubMed
34.
go back to reference Schwartz TH, Kim S, Glick RS, et al.: Supratentorial ependymomas in adult patients. Neurosurgery 1999, 44(4):721–731.CrossRefPubMed Schwartz TH, Kim S, Glick RS, et al.: Supratentorial ependymomas in adult patients. Neurosurgery 1999, 44(4):721–731.CrossRefPubMed
35.
go back to reference Metellus P, Figarella-Branger D, Guyotat J, et al.: Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients. Cancer 2008, 113(1):175–185.CrossRefPubMed Metellus P, Figarella-Branger D, Guyotat J, et al.: Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients. Cancer 2008, 113(1):175–185.CrossRefPubMed
36.
go back to reference Healey EA, Barnes PD, Kupsky WJ, et al.: The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991, 28(5):666–671; discussion 671–672.CrossRefPubMed Healey EA, Barnes PD, Kupsky WJ, et al.: The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991, 28(5):666–671; discussion 671–672.CrossRefPubMed
37.
go back to reference Paulino AC, Wen BC, Buatti JM, et al.: Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol 2002, 25(2):117–122.CrossRefPubMed Paulino AC, Wen BC, Buatti JM, et al.: Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol 2002, 25(2):117–122.CrossRefPubMed
38.
go back to reference Ruda R, Gilbert M, Soffietti R: Ependymomas of the adult: molecular biology and treatment. Curr Opin Neurol 2008, 21(6):754–761.CrossRefPubMed Ruda R, Gilbert M, Soffietti R: Ependymomas of the adult: molecular biology and treatment. Curr Opin Neurol 2008, 21(6):754–761.CrossRefPubMed
39.
go back to reference Merchant TE, Fouladi M: Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 2005, 75(3):287–299.CrossRefPubMed Merchant TE, Fouladi M: Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 2005, 75(3):287–299.CrossRefPubMed
40.
go back to reference Taylor RE: Review of radiotherapy dose and volume for intracranial ependymoma. Pediatr Blood Cancer 2004, 42(5):457–460.CrossRefPubMed Taylor RE: Review of radiotherapy dose and volume for intracranial ependymoma. Pediatr Blood Cancer 2004, 42(5):457–460.CrossRefPubMed
41.
go back to reference • Merchant TE, Li C, Xiong X, et al.: Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 2009, 10(3):258–266. This is a seminal study regarding the utility of advanced radiation techniques for pediatric ependymoma.CrossRefPubMed • Merchant TE, Li C, Xiong X, et al.: Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 2009, 10(3):258–266. This is a seminal study regarding the utility of advanced radiation techniques for pediatric ependymoma.CrossRefPubMed
42.
go back to reference Schild SE, Nisi K, Scheithauer BW, et al.: The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1998, 42(5):953–958.PubMed Schild SE, Nisi K, Scheithauer BW, et al.: The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1998, 42(5):953–958.PubMed
43.
go back to reference Salazar OM, Castro-Vita H, VanHoutte P, et al.: Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 1983, 59(4):652–659.CrossRefPubMed Salazar OM, Castro-Vita H, VanHoutte P, et al.: Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 1983, 59(4):652–659.CrossRefPubMed
44.
go back to reference Shaw EG, Evans RG, Scheithauer BW, et al.: Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 1987, 13(10):1457–1462.PubMed Shaw EG, Evans RG, Scheithauer BW, et al.: Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 1987, 13(10):1457–1462.PubMed
45.
go back to reference Gornet MK, Buckner JC, Marks RS, et al.: Chemotherapy for advanced CNS ependymoma. J Neurooncol 1999, 45(1):61–67.CrossRefPubMed Gornet MK, Buckner JC, Marks RS, et al.: Chemotherapy for advanced CNS ependymoma. J Neurooncol 1999, 45(1):61–67.CrossRefPubMed
46.
go back to reference Brandes AA, Cavallo G, Reni M, et al.: A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer 2005, 104(1):143–148.CrossRefPubMed Brandes AA, Cavallo G, Reni M, et al.: A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer 2005, 104(1):143–148.CrossRefPubMed
47.
go back to reference Rojas-Marcos I, Calvet D, Janoray P, Delattre JY: Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. Neurology 2003, 61(7):1019–1020.PubMed Rojas-Marcos I, Calvet D, Janoray P, Delattre JY: Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. Neurology 2003, 61(7):1019–1020.PubMed
48.
go back to reference Chamberlain MC, Johnston SK: Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer 2009, 115(20):4775–4782.CrossRefPubMed Chamberlain MC, Johnston SK: Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer 2009, 115(20):4775–4782.CrossRefPubMed
49.
go back to reference Rehman S, Brock C, Newlands ES: A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy. Am J Clin Oncol 2006, 29(1):106–107.CrossRefPubMed Rehman S, Brock C, Newlands ES: A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy. Am J Clin Oncol 2006, 29(1):106–107.CrossRefPubMed
50.
go back to reference Soffietti R, Constanza A, Laguzzi E, et al.: Temozolomide in rare brain tumors of the adult: a prospective study [abstract]. J Clin Oncol 2005, 23:1574. Soffietti R, Constanza A, Laguzzi E, et al.: Temozolomide in rare brain tumors of the adult: a prospective study [abstract]. J Clin Oncol 2005, 23:1574.
51.
go back to reference Wright KD, Gajjar A: New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Childs Nerv Syst 2009, 25(10):1275–1282.CrossRefPubMed Wright KD, Gajjar A: New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Childs Nerv Syst 2009, 25(10):1275–1282.CrossRefPubMed
52.
go back to reference Green RM, Cloughesy TF, Stupp R, et al.: Bevacizumab for recurrent ependymoma. Neurology 2009, 73(20):1677–1680.CrossRefPubMed Green RM, Cloughesy TF, Stupp R, et al.: Bevacizumab for recurrent ependymoma. Neurology 2009, 73(20):1677–1680.CrossRefPubMed
53.
go back to reference Peschel RE, Kapp DS, Cardinale F, Manuelidis EE: Ependymomas of the spinal cord. Int J Radiat Oncol Biol Phys 1983, 9(7):1093–1096.PubMed Peschel RE, Kapp DS, Cardinale F, Manuelidis EE: Ependymomas of the spinal cord. Int J Radiat Oncol Biol Phys 1983, 9(7):1093–1096.PubMed
54.
go back to reference Nakamura M, Ishii K, Watanabe K, et al.: Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina. Spine (Phila Pa 1976) 2009, 34(21):E756–E760. Nakamura M, Ishii K, Watanabe K, et al.: Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina. Spine (Phila Pa 1976) 2009, 34(21):E756–E760.
55.
go back to reference Gomez DR, Missett BT, Wara WM, et al.: High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol 2005, 7(3):254–259.CrossRefPubMed Gomez DR, Missett BT, Wara WM, et al.: High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol 2005, 7(3):254–259.CrossRefPubMed
56.
go back to reference Volpp PB, Han K, Kagan AR, Tome M: Outcomes in treatment for intradural spinal cord ependymomas. Int J Radiat Oncol Biol Phys 2007, 69(4):1199–1204.PubMed Volpp PB, Han K, Kagan AR, Tome M: Outcomes in treatment for intradural spinal cord ependymomas. Int J Radiat Oncol Biol Phys 2007, 69(4):1199–1204.PubMed
57.
go back to reference Schwartz TH, McCormick PC: Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 2000, 47(3):211–218.CrossRefPubMed Schwartz TH, McCormick PC: Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 2000, 47(3):211–218.CrossRefPubMed
58.
go back to reference Shaw EG, Evans RG, Scheithauer BW, et al.: Radiotherapeutic management of adult intraspinal ependymomas. Int J Radiat Oncol Biol Phys 1986, 12(3):323–327.PubMed Shaw EG, Evans RG, Scheithauer BW, et al.: Radiotherapeutic management of adult intraspinal ependymomas. Int J Radiat Oncol Biol Phys 1986, 12(3):323–327.PubMed
59.
go back to reference Schultheiss TE, Stephens LC, Peters LJ: Survival in radiation myelopathy. Int J Radiat Oncol Biol Phys 1986, 12(10):1765–1769.PubMed Schultheiss TE, Stephens LC, Peters LJ: Survival in radiation myelopathy. Int J Radiat Oncol Biol Phys 1986, 12(10):1765–1769.PubMed
60.
go back to reference Kocak Z, Garipagaoglu M, Adli M, et al.: Spinal cord ependymomas in adults: analysis of 15 cases. J Exp Clin Cancer Res 2004, 23(2):201–206.PubMed Kocak Z, Garipagaoglu M, Adli M, et al.: Spinal cord ependymomas in adults: analysis of 15 cases. J Exp Clin Cancer Res 2004, 23(2):201–206.PubMed
61.
go back to reference Chamberlain MC: Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide. Pediatr Neurol 2001, 24(2):117–121.CrossRefPubMed Chamberlain MC: Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide. Pediatr Neurol 2001, 24(2):117–121.CrossRefPubMed
62.
go back to reference Fakhrai N, Neophytou P, Dieckmann K, et al.: Recurrent spinal ependymoma showing partial remission under Imatimib. Acta Neurochir (Wien) 2004, 146(11):1255–1258.CrossRef Fakhrai N, Neophytou P, Dieckmann K, et al.: Recurrent spinal ependymoma showing partial remission under Imatimib. Acta Neurochir (Wien) 2004, 146(11):1255–1258.CrossRef
Metadata
Title
Ependymomas in Adults
Authors
Mark R. Gilbert
Roberta Ruda
Riccardo Soffietti
Publication date
01-05-2010
Publisher
Current Science Inc.
Published in
Current Neurology and Neuroscience Reports / Issue 3/2010
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-010-0109-3

Other articles of this Issue 3/2010

Current Neurology and Neuroscience Reports 3/2010 Go to the issue